Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men

Journal of Physiology

Volumn 591, Issue 20, 2013, Pages 5047-5059

  Gliemann, Lasse ^a   Schmidt, Jakob Friis ^a   Olesen, Jesper ^b   Biensø, Rasmus Sjørup ^b   Peronard, Sebastian Louis ^a   Grandjean, Simon Udsen ^a   Mortensen, Stefan Peter ^c   Nyberg, Michael ^a   Bangsbo, Jens ^a   Pilegaard, Henriette ^b   Hellsten, Ylva ^a  

^a Department of Biology Molecular Integrative Physiology   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CHOLESTEROL; ENDOTHELIN 1; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITRATE; NITRITE; PLACEBO; PROSTACYCLIN; RESVERATROL; SIRTUIN 1; THROMBOXANE SYNTHASE; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR HEALTH; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE; FUNCTIONAL STATUS; HEALTH; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; SUPPLEMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

AGED; CARDIOVASCULAR SYSTEM; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; EPOPROSTENOL; EXERCISE; HUMANS; MALE; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; SEDENTARY LIFESTYLE; STILBENES; THROMBOXANE-A SYNTHASE; TRIGLYCERIDES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84885405201     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.258061     Document Type: Article

References (92)

1. Andersen P & Saltin B (1985). Maximal perfusion of skeletal-muscle in man. J Physiol 366, 233-249.
2. Anderson D, Phillips BJ & Yu TW (1997). The effects of vitamin C supplementation on biomarkers of oxygen radical generated damage in human volunteers with 'low' or 'high' cholesterol levels. Environ Mol Mutagen 30, 161-174.
3. Baar K (2004). Involvement of PPARγ co-activator-1, nuclear respiratory factors 1 and 2, and PPARα in the adaptive response to endurance exercise. Proc Nutr Soc 63, 269-273.
4. Bailey DM, McEneny J, Mathieu-Costello O, Henry RR, James PE, McCord JM, Pietri S, Young IS & Richardson RS (2010). Sedentary aging increases resting and exercise-induced intramuscular free radical formation. J Appl Physiol 109, 449-456.
5. Baur JA & Sinclair DA (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews Drug Discovery 5, 493-506.
6. Bergstrom J (1975). Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Inv 35, 609-616.
7. Boushel R, Gnaiger E, Calbet JAL, González-Alonso J, Wright-Paradis C, Sondergaard H, Ara I, Helge JW & Saltin B (2011). Muscle mitochondrial capacity exceeds maximal oxygen delivery in humans. Mitochondrion 11, 303-307.
8. Brasnyó P, Molnár GA, Mohás M, Markó L, Laczy B, Cseh J, Mikolás E, Szijártó IA, Mérei A, Halmai R, Mészáros LG, Sümegi B & Wittmann I (2011). Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 106, 383-389.
9. Cao G, Russell RM, Lischner N & Prior RL (1998). Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women. J Nutr 128, 2383-2390.
10. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S & Shah AM (2006). NADPH oxidases in cardiovascular health and disease. Antiox Redox Signal 8, 691-728.
11. Clifford PS & Hellsten Y (2004). Vasodilatory mechanisms in contracting skeletal muscle. J Appl Physiol 97, 393-403.
12. Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P, Hawkins M, Cohen HW & Barzilai N (2012). Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci 67, 1307-1312.
13. Davies KJ, Quintanilha AT, Brooks GA & Packer L (1982). Free radicals and tissue damage produced by exercise. Biochem Biophys Res Commun 107, 1198-1205.
14. Devries MC, Hamadeh MJ, Glover AW, Raha S, Samjoo IA & Tarnopolsky MA (2008). Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women. Free Radic Biol Med 45, 503-511.
15. Dolinsky VW, Jones KE, Sidhu RS, Haykowsky M, Czubryt MP, Gordon T & Dyck JRB (2012). Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats. J Physiol 590, 2783-2799.
16. Durrant JR, Seals DR, Connell ML, Russell MJ, Lawson BR, Folian BJ, Donato AJ & Lesniewski LA (2009). Voluntary wheel running restores endothelial function in conduit arteries of old mice: direct evidence for reduced oxidative stress, increased superoxide dismutase activity and down-regulation of NADPH oxidase. J Physiol 587, 3271-3285.
17. Ehsani AA, Ogawa T, Miller TR, Spina RJ & Jilka SM (1991). Exercise training improves left ventricular systolic function in older men. Circulation 83, 96-103.
18. Eskurza I, Monahan KD, Robinson JA & Seals DR (2004). Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing. J Physiol 556, 315-324.
19. Finkel T & Holbrook NJ (2000). Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247.
20. Förstermann U (2008). Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 5, 338-349.
21. Gomes EC, Silva AN & de Oliveira MR (2012). Oxidants, antioxidants, and the beneficial roles of exercise-induced production of reactive species. Oxid Med Cell Longev 2012, 756132.
22. Goodyear LJ & Kahn BB (1998). Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 49, 235-261.
23. Greene NP, Fluckey JD, Lambert BS, Greene ES, Riechman SE & Crouse SF (2012). Regulators of blood lipids and lipoproteins? PPARδ and AMPK, induced by exercise, are correlated with lipids and lipoproteins in overweight/obese men and women. Am J Physiol Endocrinol Metab 303, E1212-1221.
24. Hambrecht R, Adams V, Erbs S, Linke N, Kränkel Y, Shu Y, Baither S, Gielen H & Thiele F (2003). Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 107, 3152-3158.
25. Hansen AH, Nyberg M, Bangsbo J, Saltin B & Hellsten Y (2011). Exercise training alters the balance between vasoactive compounds in skeletal muscle of individuals with essential hypertension. Hypertension 58, 943-949.
26. Hart N, Sarga L, Csende Z, Koltai E, Koch LG, Britton SL, Davies KJA, Kouretas D, Wessner B & Radak Z (2013). Resveratrol enhances exercise training responses in rats selectively bred for high running performance. Food Chem Toxicol doi: 10.1016/j.fct.2013.01.051.
27. Hellsten Y, Apple FS & Sjödin B (1996). Effect of sprint cycle training on activities of antioxidant enzymes in human skeletal muscle. J Appl Physiol 81, 1484-1487.
28. Hellsten Y, Jensen L, Thaning P, Nyberg M & Mortensen S (2012a). Impaired formation of vasodilators in peripheral tissue in essential hypertension is normalized by exercise training: role of adenosine and prostacyclin. J Hypertens 30, 2007-2014.
29. Hellsten Y, Nielsen JJ, Lykkesfeldt J, Bruhn M, Silveira L, Pilegaard H & Bangsbo J (2007). Antioxidant supplementation enhances the exercise-induced increase in mitochondrial uncoupling protein 3 and endothelial nitric oxide synthase mRNA content in human skeletal muscle. Free Radic Biol Med 43, 353-361.
30. Hellsten Y, Nyberg M, Jensen LG & Mortensen SP (2012b). Vasodilator interactions in skeletal muscle blood flow regulation. J Physiol 590, 6297-6305.
31. Hidalgo C, Sánchez G, Barrientos G & Aracena-Parks P (2006). A transverse tubule NADPH oxidase activity stimulates calcium release from isolated triads via ryanodine receptor type 1 S -glutathionylation. J Biol Chem 281, 26473-26482.
32. Higashi Y, Sasaki S, Nakagawa K, Fukuda Y, Matsuura H, Oshima T & Chayama K (2002). Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. Am J Hypertens 15, 326-332.
33. Høier B, Nordsborg N, Andersen S, Jensen L, Nybo L, Bangsbo J & Hellsten Y (2011). Pro- and anti-angiogenic factors in human skeletal muscle in response to acute exercise and training. J Physiol 590, 595-606.
34. Isaksen CB & Pedersen KL (2006). 'Den nye steptest' og svært overvægtige http://fysio.dk/fafo/Afhandlinger/Bachelor/2006/Nastved/Den-nye-Steptest/
35. Jackson MJ (2011). Control of reactive oxygen species production in contracting skeletal muscle. Antioxid Redox Signal 15, 2477-2486.
36. Jansson PA, Veneman T, Nurjhan N & Gerich J (1994). An improved method to calculate adipose tissue interstitial substrate recovery for microdialysis studies. Life Sci 54, 1621-1624.
37. Jones CJ, Rikli RE & Beam WC (1999). A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport 70, 113-119.
38. Kirby BS, Voyles WF, Simpson CB, Carlson RE, Schrage WG & Dinenno FA (2009). Endothelium-dependent vasodilatation and exercise hyperaemia in ageing humans: impact of acute ascorbic acid administration. J Physiol 587, 1989-2003.
39. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P & Auwerx J (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127, 1109-1122.
40. Lawrenson L, Poole JG, Kim J, Brown C, Patel P & Richardson RS (2003). Vascular and metabolic response to isolated small muscle mass exercise: effect of age. Am J Physiol Heart Circ Physiol 285, H1023-1031.
41. Lopez-S A, Vial R, Balart L & Arroyave G (1974). Effect of exercise and physical fitness on serum lipids and lipoproteins. Atherosclerosis 20, 1-9.
42. Maeda S, Miyauchi T, Sakane M, Saito M, Maki S, Goto K & Matsuda M (1997). Does endothelin-1 participate in the exercise-induced changes of blood flow distribution of muscles in humans J Appl Physiol 82, 1107-1111.
43. Matos RS, Baroncini LAV, Précoma LB, Winter G, Lambach PH, Caron EY, Kaiber F & Précoma DB (2012). Resveratrol causes antiatherogenic effects in an animal model of atherosclerosis. Arq Bras Cardiol 98, 136-142.
44. Menzies KJ, Singh K, Saleem A & Hood DA (2013). Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis. J Biol Chem 288, 6968-6979.
45. Mikus CR, Boyle LJ, Borengasser SJ, Oberlin DJ, Naples SP, Fletcher J, Meers GM, Ruebel M, Laughlin MH, Dellsperger KC, Fadel PJ & Thyfault JP (2013). Simvastatin impairs exercise training adaptations. J Am Coll Cardiol doi: 10.1016/j.jacc.2013.02.074.
46. Miyauchi T & Masaki T (1999). Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 61, 391-415.
47. Miyazaki H, Oh-ishi S, Ookawara T, Kizaki T, Toshinai K, Ha S, Haga S, Ji LL & Ohno H (2001). Strenuous endurance training in humans reduces oxidative stress following exhausting exercise. Eur J Appl Physiol 84, 1-6.
48. Mortensen SP, Askew CD, Walker M, Nyberg M & Hellsten Y (2012a). The hyperaemic response to passive leg movement is dependent on nitric oxide; a new tool to evaluate endothelial nitric oxide function. J Physiol 590, 4391-4400.
49. Mortensen SP, Nyberg M, Winding K & Saltin B (2012b). Lifelong physical activity preserves functional sympatholysis and purinergic signalling in the human leg. J Physiol 590, 6227-6236.
50. Murase T, Haramizu S, Ota N & Hase T (2009). Suppression of the aging-associated decline in physical performance by a combination of resveratrol intake and habitual exercise in senescence-accelerated mice. Biogerontology 10, 423-434.
51. Nordsborg N, Mohr M, Pedersen LD, Nielsen JJ, Langberg H & Bangsbo J (2003). Muscle interstitial potassium kinetics during intense exhaustive exercise: effect of previous arm exercise. Am J Physiol Regul Integr Comp Physiol 285, R143-148.
52. Nyberg M, Blackwell JR, Damsgaard R, Jones AM, Hellsten Y & Mortensen SP (2012). Lifelong physical activity prevents an age-related reduction in arterial and skeletal muscle nitric oxide bioavailability in humans. J Physiol 590, 5361-5370.
53. Orallo F, Alvarez E, Camiña M, Leiro JM, Gómez E & Fernández P (2002). The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol 61, 294-302.
54. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo R (2008). Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8, 157-168.
55. Perk J et al (2012). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 33, 1635-1701.
56. Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Allenberg J, Kübler W & Bode C (1997). Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 17, 505-512.
57. Podsiadlo D & Richardson S (1991). The timed 'Up & Go': a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39, 142-148.
58. Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, Stødkilde-Jørgensen H, Møller N, Jessen N, Pedersen SB & Jørgensen JOL (2012). High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62, 1186-1195.
59. Powers SK & Lennon SL (1999). Analysis of cellular responses to free radicals: focus on exercise and skeletal muscle. Proc Nutr Soc 58, 1025-1033.
60. Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA (2012). SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15, 675-690.
61. Proctor DN, Shen PH, Dietz NM, Eickhoff TJ, Lawler LA, Ebersold EJ, Loeffler DL & Joyner MJ (1998). Reduced leg blood flow during dynamic exercise in older endurance-trained men. J Appl Physiol 85, 68-75.
62. Radak Z, Chung HY, Koltai E, Taylor AW & Goto S (2008). Exercise, oxidative stress and hormesis. Ageing Res Rev 7, 34-42.
63. Ranković G, Milicić B, Savić T, Dindić B, Mancev Z & Pesić G (2009). Effects of physical exercise on inflammatory parameters and risk for repeated acute coronary syndrome in patients with ischemic heart disease. Vojnosanit Pregl 66, 44-48.
64. Ristow M, Zarse K, Oberbach A, Klöting N, Birringer M, Kiehntopf M, Stumvoll M, Kahn CR & Blüher M (2009). Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A 106, 8665-8670.
65. Saltin B, Nazar K, Costill DL, Stein E, Jansson E, Essén B & Gollnick D (1976). The nature of the training response; peripheral and central adaptations of one-legged exercise. Acta Physiol Scand 96, 289-305.
66. Scheller D & Kolb J (1991). The internal reference technique in microdialysis: a practical approach to monitoring dialysis efficiency and to calculating tissue concentration from dialysate samples. J Neurosci Methods 40, 31-38.
67. Schildknecht S & Ullrich V (2009). Peroxynitrite as regulator of vascular prostanoid synthesis. Arch Biochem Biophys 484, 183-189.
68. Schulz E, Jansen T, Wenzel P, Daiber A & Münzel T (2008). Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10, 1115-1126.
69. Schumacher A, Peersen K, Sommervoll L, Seljeflot I, Arnesen H & Otterstad JE (2006). Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 13, 356-362.
70. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG; Inflammation and Host Response to Injury, Large Scale Collaborative Research Program (2013). Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110, 3507-3512.
71. Shemyakin A, Salehzadeh F, Esteves Duque-Guimaraes D, Böhm F, Rullman E, Gustafsson T, Pernow J & Krook A (2011). Endothelin-1 reduces glucose uptake in human skeletal muscle in vivo and in vitro. Diabetes 60, 2061-2067.
72. Silveira LR, Pereira-Da-Silva L, Juel C & Hellsten Y (2003). Formation of hydrogen peroxide and nitric oxide in rat skeletal muscle cells during contractions. Free Radic Biol Med 35, 455-464.
73. Skrobuk P, Kraemer von S, Semenova MM, Zitting A & Koistinen HA (2012). Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells. Diabetologia 55, 3051-3060.
74. Spanier G, Xu H, Xia N, Tobias S, Deng S, Wojnowski L, Forstermann U & Li H (2009). Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol 60 Suppl 4, 111-116.
75. Spratt JC, Goddard J, Patel N, Strachan FE, Rankin AJ & Webb DJ (2001). Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br J Pharmacol 134, 648-654.
76. Springer BA, Marin R, Cyhan T, Roberts H & Gill NW (2007). Normative values for the unipedal stance test with eyes open and closed. J Geriatr Phys Ther 30, 8.
77. Stauffer BL, Westby CM & DeSouza CA (2008). Endothelin-1, aging and hypertension. Curr Opin Cardiol 23, 350-355.
78. Taddei S, Galetta F, Virdis A, Ghiadoni L, Salvetti G, Franzoni F, Giusti C & Salvetti A (2000). Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation 101, 2896-2901.
79. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A & Salvetti A (2001). Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38, 274-279.
80. Taddei S, Virdis A, Mattei P & Salvetti A (1993). Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21, 929-933.
81. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, Sudano I & Salvetti A (1995). Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91, 1981-1987.
82. Taubert D & Berkels R (2003). Upregulation and activation of eNOS by resveratrol. Circulation 107, e78-e79.
83. Tiidus PM, Pushkarenko J & Houston ME (1996). Lack of antioxidant adaptation to short-term aerobic training in human muscle. Am J Physiol 271, R832-836.
84. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, Moonen-Kornips E, Hesselink MKC, Kunz I, Schrauwen-Hinderling VB, Blaak EE, Auwerx J & Schrauwen P (2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14, 612-622.
85. 2 production promotes endothelial NF-κB activation in aged rat arteries. Am J Physiol Heart Circ Physiol 293, H37-47.
86. Ungvari Z, Orosz Z, Rivera A, Labinskyy N, Xiangmin Z, Olson S, Podlutsky A & Csiszar A (2007b). Resveratrol increases vascular oxidative stress resistance. Am J Physiol Heart Circ Physiol 292, H2417-2424.
87. Wahren J, Saltin B, Jorfeldt L & Pernow B (1974). Influence of age on the local circulatory adaptation to leg exercise. Scand J Clin Lab Invest 33, 79-86.
88. Wang JC & Bennett M (2012). Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 111, 245-259.
89. Wei YH, Lu CY, Lee HC, Pang CY & Ma YS (1998). Oxidative damage and mutation to mitochondrial DNA and age-dependent decline of mitochondrial respiratory function. Ann N Y Acad Sci 854, 155-170.
90. Xia R, Webb JA, Gnall LLM, Cutler K & Abramson JJ (2003). Skeletal muscle sarcoplasmic reticulum contains a NADH-dependent oxidase that generates superoxide. Am J Physiol Cell Physiol 285, C215-221.
91. Yang Y-M, Huang A, Kaley G & Sun D (2009). eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Heart Circ Physiol 297, H1829-1836.
92. Yoshino J, Conte C, Fontana L, Mittendorfer B, Imai S-I, Schechtman KB, Gu C, Kunz I, Rossi Fanelli F, Patterson BW & Klein S (2012). Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab 16, 658-664.